Brief: Betterlife Pharma Announces Interferon Alpha-2B Covid-19 News Regarding Its Emergence As Potential Treatment For Covid-19
13/05/2020 19:20
May 13 (Reuters) - BetterLife Pharma Inc BETR.CD :
* BETTERLIFE PHARMA ANNOUNCES INTERFERON ALPHA-2B COVID-19
NEWS
REGARDING ITS EMERGENCE AS A POTENTIAL TREATMENT FOR COVID-19
Source text for Eikon: urn:newsml:reuters.com:*:nPn8q2MRHa
Further company coverage: BETR.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BetterLife Pharma
See all newsBrief: Betterlife Pharma Provides Scientific Update On Neuroplastogenic Activity Of BETR-001
Brief: Betterlife Pharma Advanced In IND-enabling Studies For BETR-001
Brief: BetterLife Announces Closing Of $1.168 Million Convertible Debentures To Further Advance IND-Enabling Studies Of Its Non-Hallucinogenic LSD-Based Drug Candidate BETR-001
Brief: Omineca Announces $2 Mln Brokered Financing Of Flow-Through Units
Brief: Betterlife Announces Pricing Of Proposed Offering Of Units